{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:56:26Z","timestamp":1781675786732,"version":"3.54.5"},"reference-count":44,"publisher":"Norwegian Medical Association","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2009,5,14]]},"DOI":"10.4045\/tidsskr.08.0078","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T13:20:54Z","timestamp":1242393654000},"page":"992-6","source":"Crossref","is-referenced-by-count":1,"title":["Hidradenitis suppurativa"],"prefix":"10.4045","volume":"129","author":[{"given":"Erlend","family":"Tolaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine Wold","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbet","family":"Sviland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Alexander","family":"T\u00f8nseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Jansen I, Altmeyer P, Plewig G. Acne inversa (alias hidradenitis suppurativa). J Eur Acad Dermatol Venereol 2001; 15: 532\u2009\u2013\u200940.","DOI":"10.1046\/j.1468-3083.2001.00303.x"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008; 59: 596\u2009\u2013\u2009601.","DOI":"10.1016\/j.jaad.2008.06.020"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996; 35: 191\u2009\u2013\u20094.","DOI":"10.1016\/S0190-9622(96)90321-7"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"von der Werth M, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000; 14: 389\u2009\u2013\u200992.","DOI":"10.1046\/j.1468-3083.2000.00087.x"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Wolkenstein P, Loundou A, Barrau K et al. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol 2007; 56: 621\u2009\u2013\u20093.","DOI":"10.1016\/j.jaad.2006.08.061"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809\u2009\u2013\u200913.","DOI":"10.1046\/j.1365-2133.2001.04137.x"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Jemec GB. Hidradenitis suppurativa. J Cutan Med Surg 2003; 7: 47\u2009\u2013\u200956.","DOI":"10.1177\/120347540300700109"},{"key":"ref=8","unstructured":"Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. I: Roenigk RK, red. Dermatologic surgery. Principles and practice. New York: Marcel Dekker, 1989: 729."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Jemec GB, Revuz J. Treatment. I: Jemec GB, Revuz J, Leyden JJ red. Hidradenitis suppurativa. Berlin: Springer-Verlag, 2006: 184\u2009\u2013\u20095.","DOI":"10.1007\/978-3-540-33101-8"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Faye O, Petit F, Poli F et al. Lymphedema as a complication of hidradenitis suppurativa in three patients. Ann Dermatol Venereol 2007; 134: 567\u2009\u2013\u20099.","DOI":"10.1016\/S0151-9638(07)89271-4"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Maclean GM, Coleman DJ. Three fatal cases of squamous cell carcinoma arising in chronic perianal hidradenitis suppurativa. Ann R Coll Surg Engl 2007; 89: 709\u2009\u2013\u200912.","DOI":"10.1308\/003588407X209392"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Hunger RE, Surovy AM, Hassan AS et al. Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor. Br J Dermatol 2008; 158: 691\u2009\u2013\u20097.","DOI":"10.1111\/j.1365-2133.2007.08425.x"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"von der Werth JM, Williams HC, Raeburn JA. The\u00a0clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000; 142: 947\u2009\u2013\u200953.","DOI":"10.1046\/j.1365-2133.2000.03476.x"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996; 134: 1057\u2009\u2013\u20099.","DOI":"10.1111\/j.1365-2133.1996.tb07942.x"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Konig A, Lehmann C, Rompel R. Cigarette smoking as a triggering factor of hidradenitis suppurativa. Dermatology 1999; 198: 261\u2009\u2013\u20094.","DOI":"10.1159\/000018126"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 1995; 133: 254\u2009\u2013\u20098.","DOI":"10.1111\/j.1365-2133.1995.tb02624.x"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Lapins J, Jarstrand C,Emstestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 1999; 140: 90\u2009\u2013\u20095.","DOI":"10.1046\/j.1365-2133.1999.02613.x"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Jemec GB, Faber M, Gutschik E et al. The bacteriology of hidradenitis suppurativa. Dermatology 1996; 193: 203\u2009\u2013\u20096.","DOI":"10.1159\/000246246"},{"key":"ref=19","unstructured":"Hay RJ. Suppurative hidradenitis. I: Burns T, Breathnach S, Cox N et al. Rook\u2019s textbook of dermatology. 7. utg. Oxford: Blackwell, 2004: 2782\u2009\u2013\u20095."},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Church JM, Fazio VW, Lavery IC et al. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohns\"s disease. Int J Colorectal Dis 1993; 8: 117\u2009\u2013\u20099.","DOI":"10.1007\/BF00341181"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Lam J, Krakowski AC, Friedlander SF. Hidradenitis suppurativa (Acne inversa): management of recaltricant disease. Pediatr Dermatol 2007; 24: 465\u2009\u2013\u200973.","DOI":"10.1111\/j.1525-1470.2007.00544.x"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J\u00a0Plast Surg 2003; 56: 451\u2009\u2013\u200961.","DOI":"10.1016\/S0007-1226(03)00177-2"},{"key":"ref=23","unstructured":"Nasjonale faglige retningslinjer for antibiotikabruk i prim\u00e6rhelsetjenesten. IS-1583. Oslo: Helsedirektoratet, 2008: 148\u2009\u2013\u200950. www.shdir.no\/vp\/multimedia\/archive\/00078\/Nasjonal_faglig_retn_78639a.pdf (4.3.2009)."},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39: 971\u2009\u2013\u20094.","DOI":"10.1016\/S0190-9622(98)70272-5"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22: 325\u2009\u2013\u20098.","DOI":"10.1111\/j.1365-4362.1983.tb02150.x"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Webster G, Del Rosso JQ. Anti-inflammatory effect of tetracyclines. Dermatol Clin 2007; 25: 133\u2009\u2013\u20095.","DOI":"10.1016\/j.det.2007.01.012"},{"key":"ref=27","unstructured":"Shah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician 2005, 72: 1547\u2009\u2013\u200952."},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Mendonca CO, Griffithits CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006; 154: 977\u2009\u2013\u20098.","DOI":"10.1111\/j.1365-2133.2006.07155.x"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Boer J, van Gemert MJ. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. J Am Acad Dermatol 1999; 40: 73\u2009\u2013\u20096.","DOI":"10.1016\/S0190-9622(99)70530-X"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Brocard A, Knol AC, Khammari A et al. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology 2007; 214: 325\u2009\u2013\u20097.","DOI":"10.1159\/000100883"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Fardet L, Dupuy A, Kerob D et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J Am Acad Dermatol 2007; 56: 624\u2009\u2013\u20098.","DOI":"10.1016\/j.jaad.2006.07.027"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol 2008; 158: 567\u2009\u2013\u200972.","DOI":"10.1111\/j.1365-2133.2007.08372.x"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Banerjee AK. Surgical treatment of hidradenitis suppurativa. Br J Surg 1992; 79: 863\u2009\u2013\u20096.","DOI":"10.1002\/bjs.1800790905"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Vickers MA. Operative management of hidradenitis suppurativa of the scrotum and perineum. J Urol 1975; 114: 414\u2009\u2013\u20096.","DOI":"10.1016\/S0022-5347(17)67044-7"},{"key":"ref=35","unstructured":"Parks RW, Parks TG. Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 1997; 79: 83\u2009\u2013\u20099."},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Watson JD. Hidradenitis suppurativa \u2013 a clinical review. Br J Plast Surg 1985; 28: 567\u2009\u2013\u20099.","DOI":"10.1016\/0007-1226(85)90022-0"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Soldin MG, Tulley P, Kaplan H et al. Chronic axillary hidradenitis \u2013 the efficacy of wide excision and flap coverage. Br J Plast Surg 2000; 53: 434\u2009\u2013\u20096.","DOI":"10.1054\/bjps.1999.3285"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg 2000; 26: 638\u2009\u2013\u200943.","DOI":"10.1046\/j.1524-4725.2000.00043.x"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Broadwater JR, Bryant RL, Petrino RA et al. Advanced hidradenitis suppurativa. Review of surgical treatment in 23 patients. Am J Surg 1982; 44: 668\u2009\u2013\u200970.","DOI":"10.1016\/0002-9610(82)90547-5"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Dabernig J, Sorensen K, Shaw-Dunn J et al. The thin circumflex scapular artery perforator flap. J\u00a0Plast Reconstr Aesthet Surg 2007; 60: 1082\u2009\u2013\u200996.","DOI":"10.1016\/j.bjps.2006.10.002"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Rees L, Moses M, Clibbon J. The anterolateral thigh (ALT) flap in reconstruction following radical excision of groin and vulval hidradenitis suppurativa. J Plast Reconstr Aesthet Surg 2007; 60: 1363\u2009\u2013\u20095.","DOI":"10.1016\/j.bjps.2007.08.013"},{"key":"ref=42","doi-asserted-by":"crossref","unstructured":"Ong WC, Lim TC, Lim J et al. Suction-curettage: treatment of axillary hyperhidrosis and hidradenitis. Plast Reconstr Surg 2003; 111: 958\u2009\u2013\u20099.","DOI":"10.1097\/00006534-200302000-00097"},{"key":"ref=43","doi-asserted-by":"crossref","unstructured":"Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: A retrospective follow-up study of patients with hidradenitis suppurativa. J Am Acad Dermatol 2002; 47: 280\u2009\u2013\u20095.","DOI":"10.1067\/mjd.2002.124601"},{"key":"ref=44","unstructured":"Fr\u00f6hlich D, Baaske DE, Glatzel M. Radiotherapy of\u00a0hidradenitis suppurativa \u2013 still valid today? Strahlenther Onkol 2000; 176: 286\u2009\u2013\u20099."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T05:27:54Z","timestamp":1781674074000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2009\/05\/oversiktsartikkel\/hidradenitis-suppurativa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,14]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,5,14]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.08.0078","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,14]]}}}